🚨 WHEN A GLOBAL LEADER HIGHLIGHTS $HUMA IN ITS REPORT
Fresenius Medical Care ($FMS), the world’s dialysis giant, mentioned Humacyte in its Q2 2025 earnings presentation.
👉 The positive impact of the Humacyte remeasurement is clearly highlighted in their investor slides.
💡 Translation:
- They hold $HUMA and are keeping their position.
- They are publicly valuing this partnership/investment.
- This isn’t just an accounting line — it’s a signal of confidence in the company’s potential.
📊 When a global leader talks about you in their earnings, it’s never by accident.
Buy the @Huma Finance 🟣 Now👇